BG-12, an oral treatment for relapsing-remitting forms of multiple sclerosis, has received FDA approval and will be sold under the name Tecfidera. Manufactured by Biogen Idec, it is the third…
Read More
Multiple Scleresis: Colorado Pediatric Study On April 2, 2013 CBS aired a story about MS in children. During the interview Sr. Teri Schriener was interviewed. Learn more about what…
To learn more about childhood MS, we spoke with Dr. Teri Schreiner, a pediatric neurologist at the Rocky Mountain MS Center at Anschutz Medical Campus. Currently, Dr. Schreiner treats about…
Retinal Thinning and Multiple Sclerosis: What Your Eyes Are Saying BREAKING NEWSExcerp from eMS News, the electronic Newsletter of the Rocky Mountain MS Center Active multiple sclerosis (MS) outside of…
Five Days Until Colorado Gives Day! Colorado Gives Day, December 4, 2012, is an initiative to increase philanthropy in Colorado through online giving. Last year we raised almost $20,000…
In the latest issue of InforMS, we explore what we know about the potential benefits and harms of the existing therapies for multiple sclerosis, how we think today about the…
While there’s no MS cure, new drugs have made the feared disease recedeDenver Post
Rocky Mountain Multiple Sclerosis Center’s Medical Director, Dr. Tim Vollmer, Selected as Principal Investigator for NeuroNEXT Clinical Site
Renowned MS expert to speak: Advances in treament moving quickly
Novartis’s Gilenya Loses Market Share After Safety Review“If they have any history of any kind of cardiac disease, we won’t consider the drug,” Vollmer said in a telephone interview. “For…